These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3493046)
1. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura. Kelton JG; Moore JC; Murphy WG Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046 [TBL] [Abstract][Full Text] [Related]
2. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Moore JC; Murphy WG; Kelton JG Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the role of von Willebrand factor in thrombotic thrombocytopenic purpura. Lian EC; Siddiqui FA Blood; 1985 Nov; 66(5):1219-21. PubMed ID: 3876857 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. Danton MC; Zaleski A; Nichols WL; Olson JD J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492 [TBL] [Abstract][Full Text] [Related]
6. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052 [TBL] [Abstract][Full Text] [Related]
7. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Chow TW; Turner NA; Chintagumpala M; McPherson PD; Nolasco LH; Rice L; Hellums JD; Moake JL Am J Hematol; 1998 Apr; 57(4):293-302. PubMed ID: 9544973 [TBL] [Abstract][Full Text] [Related]
8. Binding of platelet agglutinating protein p37 from the plasma of a patient with thrombotic thrombocytopenic purpura to human platelets. Lian EC; Siddiqui FA Thromb Haemost; 1991 Jan; 65(1):96-101. PubMed ID: 2024244 [TBL] [Abstract][Full Text] [Related]
9. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen. Ruan CG; Du XP; Xi XD; Castaldi PA; Berndt MC Blood; 1987 Feb; 69(2):570-7. PubMed ID: 3801672 [TBL] [Abstract][Full Text] [Related]
10. [Inhibition of Fc-receptor dependent platelet aggregation by monoclonal antibodies against the glycoprotein IIb-IIIa complex]. Vinogradov DV; Vlasik TN; Agafonova OG; Vasil'ev SA; Lagutina NIa; Makarov VA; Berndt M; Mazurov AV Biokhimiia; 1991 May; 56(5):787-97. PubMed ID: 1747408 [TBL] [Abstract][Full Text] [Related]
11. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo. Mayr FB; Knöbl P; Jilma B; Siller-Matula JM; Wagner PG; Schaub RG; Gilbert JC; Jilma-Stohlawetz P Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617 [TBL] [Abstract][Full Text] [Related]
12. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against porcine platelet membrane glycoproteins Ib and IIb/IIIa. Takami H; Nichols WL; Kaese SE; Miller RS; Katzmann JA; Bowie EJ Blood; 1988 Nov; 72(5):1740-7. PubMed ID: 3140912 [TBL] [Abstract][Full Text] [Related]
14. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Murphy WG; Moore JC; Kelton JG Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176 [TBL] [Abstract][Full Text] [Related]
15. Heparin-associated thrombocytopenia: observations on the mechanism of platelet aggregation. Adelman B; Sobel M; Fujimura Y; Ruggeri ZM; Zimmerman TS J Lab Clin Med; 1989 Feb; 113(2):204-10. PubMed ID: 2783722 [TBL] [Abstract][Full Text] [Related]
16. Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib. George JN; Torres MM Blood; 1988 May; 71(5):1253-9. PubMed ID: 3258766 [TBL] [Abstract][Full Text] [Related]
17. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers. Weiss HJ; Sussman II Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody to glycoprotein Ib inhibits both thrombin- and ristocetin-induced platelet aggregations. Yamamoto N; Kitagawa H; Tanoue K; Yamazaki H Thromb Res; 1985 Sep; 39(6):751-9. PubMed ID: 2417361 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers. Zucker MB; Puszkin EG; Sussman II; Mauss EA J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846 [TBL] [Abstract][Full Text] [Related]
20. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets. Parker RI; Gralnick HR Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]